NCT03248297View on ClinicalTrials.gov

Antibiotic Prophlaxis for High-risk Laboring Women in Low Income Countries

PHASE4CompletedINTERVENTIONAL
Enrollment

756

Participants

Timeline

Start Date

January 12, 2018

Primary Completion Date

May 15, 2020

Study Completion Date

October 1, 2020

Conditions
Postpartum SepsisPostpartum EndometritisPostpartum Fever
Interventions
DRUG

Azithromycin

Azithromycin tablet

DRUG

Azithromycin and amoxicillin

azithromycin and amoxicillin

DRUG

Placebo

Placebo tablet

Trial Locations (1)

Unknown

Cameroon Baptist Convention Health Services, Bamenda

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

University of Alabama at Birmingham

OTHER

NCT03248297 - Antibiotic Prophlaxis for High-risk Laboring Women in Low Income Countries | Biotech Hunter | Biotech Hunter